172 related articles for article (PubMed ID: 19939227)
1. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.
Darvesh S; Reid GA; Martin E
Curr Alzheimer Res; 2010 Aug; 7(5):386-400. PubMed ID: 19939227
[TBL] [Abstract][Full Text] [Related]
2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
6. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
Ciro A; Park J; Burkhard G; Yan N; Geula C
Curr Alzheimer Res; 2012 Jan; 9(1):138-43. PubMed ID: 21244353
[TBL] [Abstract][Full Text] [Related]
7. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Geula C; Mesulam M
Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.
Wright CI; Guela C; Mesulam MM
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):683-6. PubMed ID: 8421706
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
Geula C; Greenberg BD; Mesulam MM
Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
[TBL] [Abstract][Full Text] [Related]
10. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
Mesulam MM; Geula C; Morán MA
Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
12. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
Schätz CR; Geula C; Mesulam M
Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
15. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase histochemistry in the human brain: effect of various fixation and storage conditions.
Morán MA; Gómez-Ramos P
J Neurosci Methods; 1992 Jun; 43(1):49-54. PubMed ID: 1528073
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
Kalaria RN; Kroon SN; Grahovac I; Perry G
Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.
Morán MA; Mufson EJ; Gómez-Ramos P
Acta Neuropathol; 1993; 85(4):362-9. PubMed ID: 8480510
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
Giacobini E
Drugs Aging; 2001; 18(12):891-8. PubMed ID: 11888344
[TBL] [Abstract][Full Text] [Related]
20. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
